ZA200201388B - Ophthalmic fluid. - Google Patents

Ophthalmic fluid.

Info

Publication number
ZA200201388B
ZA200201388B ZA200201388A ZA200201388A ZA200201388B ZA 200201388 B ZA200201388 B ZA 200201388B ZA 200201388 A ZA200201388 A ZA 200201388A ZA 200201388 A ZA200201388 A ZA 200201388A ZA 200201388 B ZA200201388 B ZA 200201388B
Authority
ZA
South Africa
Prior art keywords
ophthalmic fluid
tear film
fatty acid
ocular substrate
lipid layer
Prior art date
Application number
ZA200201388A
Other languages
English (en)
Inventor
Sly Anthony William
Original Assignee
Planned Products Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Planned Products Pty Ltd filed Critical Planned Products Pty Ltd
Publication of ZA200201388B publication Critical patent/ZA200201388B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
ZA200201388A 1999-08-18 2002-02-19 Ophthalmic fluid. ZA200201388B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ2281A AUPQ228199A0 (en) 1999-08-18 1999-08-18 Ophthalmic fluid

Publications (1)

Publication Number Publication Date
ZA200201388B true ZA200201388B (en) 2003-05-28

Family

ID=3816456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201388A ZA200201388B (en) 1999-08-18 2002-02-19 Ophthalmic fluid.

Country Status (13)

Country Link
US (2) US7115667B2 (ko)
EP (1) EP1214068B1 (ko)
JP (1) JP2003506486A (ko)
KR (1) KR100727008B1 (ko)
CN (1) CN1197566C (ko)
AT (1) ATE342718T1 (ko)
AU (1) AUPQ228199A0 (ko)
CA (1) CA2380741A1 (ko)
DE (1) DE60031425D1 (ko)
HK (1) HK1049801B (ko)
NZ (1) NZ517158A (ko)
WO (1) WO2001012179A1 (ko)
ZA (1) ZA200201388B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076695A1 (en) * 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
ATE439121T1 (de) * 2004-02-26 2009-08-15 Bausch & Lomb Viskoelastische alginat-zusammensetzung, herstellungsverfahren und verpackung
JP2008505177A (ja) 2004-07-01 2008-02-21 ザ・シェペンズ・アイ・リサーチ・インスティテュート・インコーポレーテッド 目の障害および状態を治療するための組成物および方法
FR2891187B1 (fr) * 2005-09-29 2010-06-04 Centre Nat Rech Scient Procede de preparation d'une surface polymere orientee et nanostructuree.
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US20080166393A1 (en) * 2007-01-05 2008-07-10 Grant Robert K Eye Medication Delivery System
WO2009005716A1 (en) * 2007-06-29 2009-01-08 The Trustees Of Columbia University In The City Of New York Utilization of artificial human lipids reconstituted as artificial tears for the stabilization application of ophthalmic therapeutics
TWI506333B (zh) * 2008-12-05 2015-11-01 Novartis Ag 用以傳遞疏水性舒適劑之眼用裝置及其製造方法
WO2015187997A1 (en) * 2014-06-04 2015-12-10 Tersus Pharmaceuticals, LLC METHODS OF TREATING CHRONIC DRY EYE DISEASE USING C16:1n7 PALMITOLEATE AND DERIVATIVES THEREOF
DE102019112086B3 (de) 2019-05-09 2020-08-06 Saier Verpackungstechnik Gmbh & Co. Kg Behälter mit einem von einer Hülle umgebenen Kern

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608484B2 (ja) * 1979-02-27 1985-03-04 東洋コンタクトレンズ株式会社 コンタクトレンズ用洗浄保存剤
EP0459148B1 (en) * 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0656779B1 (en) * 1992-08-28 2000-04-12 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
WO1998016217A1 (en) * 1996-10-17 1998-04-23 Isaacs Charles E Disinfecting contact lenses
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers

Also Published As

Publication number Publication date
US7115667B2 (en) 2006-10-03
JP2003506486A (ja) 2003-02-18
US20040167218A1 (en) 2004-08-26
WO2001012179A1 (en) 2001-02-22
KR20020050228A (ko) 2002-06-26
HK1049801A1 (en) 2003-05-30
HK1049801B (zh) 2005-12-02
AUPQ228199A0 (en) 1999-09-09
KR100727008B1 (ko) 2007-06-14
EP1214068B1 (en) 2006-10-18
CA2380741A1 (en) 2001-02-22
US20070021503A1 (en) 2007-01-25
EP1214068A4 (en) 2004-05-12
DE60031425D1 (de) 2006-11-30
NZ517158A (en) 2003-10-31
EP1214068A1 (en) 2002-06-19
CN1373661A (zh) 2002-10-09
CN1197566C (zh) 2005-04-20
ATE342718T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
ZA200201388B (en) Ophthalmic fluid.
DE59808773D1 (de) Verwendung synthetischer Triglyceride auf Basis konjugierter Linolsäure zur Herstellung von Mitteln zur Behandlung von katabolischen Zuständen
TR199701276T1 (xx) Biyoaktif bile�ikler olarak 1,3-propan diol t�revleri.
CA2346627A1 (en) Sheet with oily ingredient-containing layer
AR242111A1 (es) Un procedimiento para producir concentrados refinados de aceite de pescado conteniendo esteres de alquilo de acidos omega-3 eicosapentaenoico y docosahexaenoico.
WO2004085582A3 (en) Lipid-improving agent and composition containing lipid-improving agent
ES2109645T3 (es) Lente de contacto multifocal.
IL117251A (en) Enzymatic process for obtaining polyunsaturated fatty acid triglyceride concentrates
ID17466A (id) Proses pembuatan asam dokosaheksanoat dan asam dokosapentanoat
WO2000009639A3 (en) Fatty ester combinations
DK1152755T3 (da) Essentielle fedtsyrer til forebyggelse af cardiovaskulære tilfælde
WO2004078166A3 (en) Use of omega-3-fatty acids in the treatment of diabetic patients
MY104981A (en) Tailored beta-prime stable triglyceride hardstock
TR199701098T1 (xx) Trigliserid ya�lar�n�n fraksiyonlanmas�.
AU1808295A (en) Hydrogenation of unsaturated fats, fatty acids or fatty acid esters
AU698903B2 (en) Edible plastic spread
ES2143067T3 (es) Procedimiento para la preparacion de esteres acrilicos refinados.
JP2003506486A5 (ko)
DE60321801D1 (de) Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel
AU2003301263A8 (en) Three layer tear formulation
WO2002049582A3 (de) Kosmetische und dermatologische lichtschutzformulierungen mit einem gehalt an benzotriazolderivaten und oberflächenaktiven zitronensäureestern
CA2186767A1 (en) Fractionation of triglyceride oils
PE97299A1 (es) Formas de dosificacion de solucion encapsulada de sertralina
AU3776595A (en) Process for the hydrolysis of the triglycerides of polyunsaturated fatty acids
AR024083A1 (es) Empleo de emulsiones o/w en procesos de fermentacion